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Abstract
Objective: We assessed the uptake of prevention of mother-to-child transmission (PMTCT) services in a cohort of HIV
infected women in care at The AIDS Support Organization Jinja and Kampala in Uganda, who were trying to conceive,
over a period of 24 months, to inform the strengthening of PMTCT service access for women in care.
Results: Of the 299 women 127 (42.5%) reported at least one pregnancy within 24 months; 61 women (48.0%) deliv‑
ered a live child. Of the 55 who had a live birth at the first pregnancy, 54 (98.2%) used antenatal care (ANC) starting at
15.5 weeks of gestation on average and 47/49 (95.9%) delivered at a health facility. Excluding miscarriages, 54 (98.2%)
received ARVs during pregnancy. Of the 49 live births with post-delivery data, 37 (75.5%) tested the infant for HIV. 79
of the 127 (68.7%) spoke with providers about childbearing. Communication with providers was associated with ANC
use (65.8% vs. 41.7%; p = .015). Despite the high rate of miscarriages and late ANC start, this study shows very high
uptake of PMTCT services among PLHIV in care and their infants. Improved provider–client communication could
enhance ANC attendance and PMTCT outcomes among HIV infected women in care.
Keywords: PMTCT, Service utilization, HIV infected women in care
Introduction
Access to prevention of mother-to-child transmission of
HIV (PMTCT) services is critical to elimination of vertical transmission of HIV [1]. Several countries, including
Uganda have made remarkable progress towards elimination of vertical transmission of HIV [2, 3]. However,
some bottlenecks remain in ensuring wider access to and
utilization of services across the PMTCT cascade [1–3].
HIV infected women who are unaware of their HIV status or are aware but not yet in care at conception pose
a major challenge to the provision of effective PMTCT
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services [2, 3]. Pregnant women of unknown HIV status
must receive an HIV diagnosis and if positive, a referral
to PMTCT services amidst multiple competing priorities. Those who are diagnosed with HIV but not in care
must quickly overcome their initial barriers to linkage to
care and ensure they access PMTCT services [4]. Further,
delay to initiate and sustain antenatal care (ANC) and
low facility based deliveries create additional challenges
for PMTCT service uptake [5–7].
Many countries have made progress towards the
UNAIDS 90-90-90 targets, diagnosis of at least 90% of
the HIV infected individuals, initiation of antiretroviral
therapy (ART) for 90% of those diagnosed and achieving
viral suppression for 90% of those initiating ART [3, 8].
This provides an opportunity to integrate antenatal care
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(ANC) services including early and sustained PMTCT
services for PLHIV in care [9, 10]. Since women in care
frequently interface with the health system, they would
ideally initiate ANC earlier, attend the required number of visits, and deliver at health facilities all of which
are associated with better outcomes. Women who plan
their pregnancies and intentionally conceive while in
care should be even more vigilant with accessing PMTCT
services.
Unfortunately, the integration of SRH services in HIV
care is a long-standing challenge despite the high fertility among PLHIV in sub-Saharan Africa [11–17]. In this
analysis, we assessed the uptake of PMTCT services in a
cohort of HIV infected women in care who were trying to
conceive to inform the strengthening of PMTCT service
access for women in care.
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the participant delivered a child, a survey was scheduled
1 month after the delivery.
Measures

This study was conducted as part of a larger cohort study
of safer conception among PLHIV in care with fertility
intentions.

Interviews were administered in Luganda, the most
common language in the study setting, using computerassisted personal interview software. The measures were
developed by the study team and have been described
elsewhere [18]. Measures included basic socio-demographic characteristics, fertility desires and intentions,
and childbearing history including the number of living
children, history ANC attendance, and access to ARVs
by the woman and exposed infant. Women were asked
if they attended ANC and what gestation week they
had their first visit, if they received ARVs prior to, during pregnancy or after pregnancy. The CD4 data was
obtained through a review of patient records. Other
variables included venue of the delivery (including health
facility, with traditional birth attendants or at home),
receipt of post-natal care (PNC), and infant services
including ARVs for prophylaxis, early infant diagnosis
(EID), EID timing, and the outcome of the test (positive,
negative, did not get results).

Study setting

Data analysis

The study was conducted at two sites within The AIDS
Support Organization (TASO) in Uganda [18, 19]. TASO
Kampala located next to the Mulago National Referral
Hospital and TASO Jinja within the Jinja Regional Referral Hospital in Jinja district. At the time, TASO Mulago
had > 8300 active clients in care while TASO Jinja had
> 7600 clients. TASO integrated family planning services
and provided ART to HIV infected pregnant women on
site. Women were referred to Mulago and Jinja hospitals
for ANC and delivery services, although TASO provided
pregnancy monitoring and related services onsite.

The main outcomes were ANC attendance and receipt of
PMTCT ART. Descriptive statistics were conducted to
describe characteristics of study participants, and access
to ANC and PMTCT services by the women and exposed
infant. With near universal access to ANC and PMTCT
ART among women who had live births, we did not
examine the correlates of ANC and PMTCT ART. This
paper is thus largely a descriptive analysis of PMTCT
service uptake. We however we conducted bivariate
statistics of the correlates of child HIV testing and provider–client communication (Chi Square tests, 2-tailed
independent t-tests) were used to examine the baseline
correlates. A p value of < .05 was used to represent a significant difference. SPSS version 15.0 was used for data
analysis.

Main text
Methods
Study design

Participant selection, eligibility screening, and interviews

The primary study from which these data were derived
included 400 PLHIV in care (including 299 HIV-infected
women) and was powered to evaluate the use of use of
safer conception methods [18]. The current analysis
includes 127 women who reported at least one pregnancy within the 24 months of follow-up. Clients were
eligible for study participation if they were ≥ 18 years,
married or in a committed heterosexual relationship,
and intended to conceive a child within 24 months. The
cohort was recruited between May and October of 2013.
A brief screening was conducted by the triage personnel. Those who were likely eligible were referred to the
research coordinator for detailed screening and consent
procedures before the interview. Follow-up interviews
were conducted at 6-month intervals for 24 months. If

Results

Overall, 299 HIV-infected women with fertility intentions were enrolled, 127 (42.5%) of whom had at least
one pregnancy during the study (Table 1). Of the
127, 18 (14.2%) had two or more pregnancies within
24 months. Repeat pregnancies were reported by one of
the 55 women who had a live birth in their first pregnancy, compared to 16 of 69 (23.2%) who had stillbirths
and/or abortions/miscarriages at the first pregnancy
(the remaining 3 participants were still pregnant at
the end of the study and we were unable to ascertain
their outcome). Of the 17 people who had more than
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Table 1 Socio-demographic characteristics, pregnancy
care processes, and outcomes among female participants
who had a pregnancy during the course of the study
Variable

N/mean Percentage/SD
N = 127a

Age (years)

31.7

SD = 6.0

Education (any secondary schooling)

51

40.2%

Married to partner

46

36.2%

HIV status of partner
Negative

39

30.7%

Positive

45

35.4%

Unknown
Partner is aware of respondent’s HIV status

43

33.9%

94

74.0%

Baseline CD4 count

449

Months since HIV diagnosis

63.4

SD = 303

SD = 50.9

On ART at baseline

78

61.4%

Number of children prior to enrollment

2.5

Communicated with provider about desire
to have a child

79/115

SD = 1.5

68.7%

Received ANC during pregnancy

73/121

60.3%

Received PMTCT ART during pregnancy

103/124

83.1%

Outcome of first pregnancy during study
Successful delivery

55

43.3%

Miscarriage

67

52.8%

Induced abortion

1

.8%

Still birth

1

.8%

Still pregnant at end of study (outcome
undetermined)

3

2.4%

a

The percent values represent the percentages of the participants out of the
total sample

one pregnancy, 7 had a successful pregnancy on their
second or third try during the course of the study.
Overall, 61 participants delivered a child during the
study. The data reported on pregnancy care processes
and outcomes in the remainder of the paper is based
only on data from the first pregnancy reported by the
participant. Whereas the occurrence of the second
pregnancies and their outcomes was recorded, the
comprehensive ANC and service utilization was not
documented for subsequent pregnancies.
ANC care and delivery

Among 73 women who used ANC at least once, care
started at an average of 15.5 weeks of gestation (range
4–36 weeks). Among the 55 who delivered a live child,
54 (98.2%) used ANC, compared to 18 of 64 (28.1%)
who did not successfully give birth (5 others who did not
deliver a child had missing data) (p = .000). Miscarriages
were experienced at an average of 13.0 weeks of gestation
(71.4% within first trimester), which may explain why so

many did not get to the point of engaging in ANC. Overall, 47/49 (95.9%) delivered at a health facility (6 had
missing data).
Received ART (PMTCT services)

Overall, 103 (81.1%) received ART during pregnancy,
including 72 (69.9%) who were on ART prior to conception and 31 (30.1%) who initiated ART during pregnancy—started at a mean of 11.2 (SD = 6.6; median = 12)
weeks of gestation (range 1–24 weeks). 54 of the 55
(98.2%) women who gave birth used ART during pregnancy, compared to 47 of 67 whose pregnancy did
not end in a successful delivery (2 had missing data)
(p = .000). Of those on ART, 17% (17/100) reported
missed doses (3 missing data) at any time during the
pregnancy.
Receipt of PMTCT infant services

Of these 49 women with post-delivery data, 37 (75.5%)
reported that the infant had been tested for HIV, of
whom 28 were reportedly HIV-negative, while 9 (24.3%)
did not return for the results. None reported that their
child tested positive. All but one of the children were
tested within first 2 months of life, and the other was
tested at week 12. There were no significant correlates
of child HIV testing among demographics, HIV characteristics, and psychosocial variables. 47 (95.9%) of the
49 respondents reported that the infant was given nevirapine prophylaxis at birth. Further, 36/48 (75.0%) of the
infants received cotrimoxazole (1 missing). All 49 participants breastfed and 2 of these reported mixed feeding.
Communication with provider about childbearing

79/127 (68.7%; 12 missing) spoke with providers about
childbearing prior to pregnancy. Communication with
providers was associated with ANC use (65.8% vs. 41.7%;
Chi square = 5.9; p = .015), and use of PMTCT (87.3%
vs. 72.2%; p = .047), but not the likelihood of a successful delivery (46.8% vs. 36.1%; p = .288) or whether or not
the child was tested for HIV among those who had a live
birth (78.9% vs. 61.5%; p = .214).
Discussion

These data show high uptake of ANC and PMTCT services with near universal ANC attendance (98%), delivery at health facilities (96%), and receipt of ARVs (98%)
during pregnancy. The ANC attendance and uptake of
ARVs during pregnancy in this population is close to
the national level indicators (95 and 93%, respectively)
[3]. However, the ANC attendance started late and
could be improved. Close to two-thirds of the women
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on ART started treatment prior to pregnancy, which is
also not surprising—the percentage of HIV+ women on
ART prior to pregnancy has grown over the years due
to expanded access to Option B+, and many women on
ART having repeat pregnancies [3]. This percentage will
likely continue to grow with scale-up of Option B+ and
is indeed a desirable scenario as it reduces the challenges
of initiation of ART among newly diagnosed individuals
[2, 3].
Despite the poor pregnancy outcomes, these data
indicate that ANC and PMTCT service uptake could be
enhanced by having more PLHIV in care prior to conception even for persistently challenging indicators such
as facility based deliveries (estimated at 57% in the general population in Uganda vs. 96% in this study) [20, 21].
However, more attention is needed to enhance provider–
client communication and earlier ANC attendance. EID
within 8 weeks of childbirth has also been a difficult
indicator, with current estimates at < 50% [3]. However,
almost three quarters of the participants in this sample
had their infants tested for HIV, with almost all of the
infants tested within 8 weeks. The high testing is however dampened by about a quarter of those testing not
receiving results. Some studies have reported challenges
with infant testing even for PLHIV in care, including
fear of HIV diagnosis among their infants, among other
challenges [22]. Receipt of ARVs for prophylaxis among
exposed infants, was near universal probably due to very
high facility based deliveries. Failure to deliver at health
facilities has been associated with low ARV prophylaxis
access among infants [22].
About two-thirds of PLHIV discussed childbearing
with their providers prior to conception, which may have
positively impacted on their ANC attendance. There is
however room for further improvements in provider
communication coupled with comprehensive information to address some of the highlighted gaps including
receipt of EID results and cotrimoxazole uptake.
Conclusion

Although not primarily designed to assess uptake of
PMTCT services, this study shows very high uptake of
PMTCT services, ANC attendance, and facility based
deliveries among HIV infected women in care, a potential indicator of improved MCH and PMTCT outcomes
with increased enrollment into HIV care of PLHIV. These
benefits could be enhanced with improved client-provider communication and earlier ANC attendance. More
effort is also required to further improve EID and cotrimoxazole uptake among infants.
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Limitations

This study was not primarily designed to assess uptake of
PMTCT services among PLHIV in care and did not have
sufficient power to assess the correlates of service uptake.
Similarly, service uptake data was not available on all
pregnancies particularly those that conceived later into
the study. However, the study provides pointers to the
potentially beneficial MCH and PMTCT effects arising
from increased enrollment of PLHIV in care, which can
be further assessed through larger studies.
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